Efficacy of platinum chemotherapy agents in adenosquamous carcinoma of the pancreas.

医学 化疗 腺鳞癌 肿瘤科 胰腺 内科学 癌症 腺癌
作者
Vasiliki Michalaki,Αntonios Vezakis,George Frangoulidis,Konstantinos Bramis,T. Theodosopoulos,Dina Tiniakos,Manousos Konstandoulakis,Christos Papadimitriou
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:42 (16_suppl): e16317-e16317
标识
DOI:10.1200/jco.2024.42.16_suppl.e16317
摘要

e16317 Background: Adenosquamous carcinoma of the pancreas (ASCP) is an aggressive, infrequent subtype of pancreatic cancer that combines a glandular and squamous component and is associated with poor survival. Data regarding adjuvant therapy remain controversial. Methods: Patients with advanced PASC from 2005 to 2021 were consecutively included in this retrospective study. Overall survival (OS) and progression-free survival (PFS) were evaluated by Kaplan-Meier method. Results: Eighteen PASC patients treated surgically were included (median age, 69.3 years; males, 58.2%). All patients received adjuvant chemotherapy. Ten patients (55%) received newer platinum based regimen combination (FOLFIRINOX) and eight patients (45%) received gemcitabine-based regimens. Platinum based regimen as compared to gemcitabine regimen showed an improvement of overall response rate (42.5% and 12.3 %, p=0.001), PFS (median,10.4 versus 3.1 months, p=0.03) and OS (median, 15.8 vs 6.9 months, p=0.21).Multivariate analysis revealed that, among all patients (n=18), the following factors were independently predictive of poor survival: margin-positive resection (HR =3,15; 95% CI, 1.5-5.9; P<0.001), lymph node involvement (HR =2.9; 95% CI, 1.7 -7.5; P=0.003), and lack of inclusion of a platinum agent in the adjuvant regimen (HR =2.6; 95% CI, 1.5 -4.9; P=0.035). Conclusions: Given the rarity of ASC, optimal management remains poorly defined, particularly in the postoperative period. Therapies based on platinum chemotherapeutics may be preferable to all other chemotherapy regimens.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马想毕业完成签到,获得积分10
刚刚
Pan完成签到,获得积分10
刚刚
九儿完成签到 ,获得积分10
1秒前
车紫霜完成签到,获得积分10
2秒前
SYLH应助yongtao采纳,获得10
2秒前
董涛完成签到,获得积分10
5秒前
科研通AI5应助xiaxue采纳,获得10
5秒前
充电宝应助Anyemzl采纳,获得10
5秒前
pw发布了新的文献求助50
6秒前
雾影觅光发布了新的文献求助10
6秒前
yar应助科研鸟采纳,获得10
6秒前
CC发布了新的文献求助10
6秒前
muyingleng完成签到,获得积分10
7秒前
隐形曼青应助强健的冰棍采纳,获得10
7秒前
研友_nV2pkn发布了新的文献求助10
8秒前
大个应助iiiid采纳,获得10
8秒前
微笑访枫完成签到,获得积分20
9秒前
完美世界应助小李叭叭采纳,获得10
9秒前
9秒前
QZZ发布了新的文献求助10
9秒前
9秒前
桐桐应助yingqing采纳,获得10
10秒前
10秒前
呆萌枕头完成签到,获得积分10
11秒前
yongtao完成签到,获得积分10
11秒前
科研通AI5应助wxt采纳,获得10
13秒前
13秒前
simey发布了新的文献求助10
13秒前
15秒前
gujian发布了新的文献求助10
15秒前
17秒前
Ava应助小任性采纳,获得10
17秒前
专注的乐荷给专注的乐荷的求助进行了留言
17秒前
英俊的铭应助Diffileft采纳,获得10
18秒前
19秒前
Zzz完成签到,获得积分10
19秒前
端庄蚂蚁完成签到,获得积分10
20秒前
20秒前
20秒前
科研通AI2S应助啦啦啦采纳,获得10
21秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971078
求助须知:如何正确求助?哪些是违规求助? 3515742
关于积分的说明 11179305
捐赠科研通 3250852
什么是DOI,文献DOI怎么找? 1795501
邀请新用户注册赠送积分活动 875868
科研通“疑难数据库(出版商)”最低求助积分说明 805207